3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Neurofibromatoses
1
Neurofibroma, Plexiform
1
Neurofibroma
1
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
1
Colonic Neoplasms
1
Interventions
Magnetic Resonance Spectroscopy
3
Fluorouracil
3
Oxaliplatin
2
Leucovorin
2
Cholecalciferol
2
Cetuximab
2
sodium thiosulfate
1
nilotinib
1
gallium 68 PSMA-11
1
epigallocatechin gallate
1
delta-8-tetrahydrocannabinol
1
clevudine
1
X-Rays
1
Vaccines
1
Tea
1
Specimen Handling
1
Reverse Transcriptase Polymerase Chain Reaction
1
Receptor Protein-Tyrosine Kinases
1
Radiotherapy
1
Platinum
1
Pentoxifylline
1
Panitumumab
1
Microscopy, Electron
1
Metastasectomy
1
Irinotecan
1
Hyperthermic Intraperitoneal Chemotherapy
1
Granulocyte-Macrophage Colony-Stimulating Factor
1
Folfox protocol
1
Fluorodeoxyglucose F18
1
FAPI-46
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase EARLY_PHASE1
×
Colonic Neoplasms
×
nilotinib
×
Clear all
NCT02774512
2017-10-06
ZAK-0
Institut Bergonié
Phase EARLY_PHASE1
Withdrawn